InterviewsJanuary 15, 2021 Journey Colab: Including Traditional Communities in the Plant-Based Medicine Boom
PressJanuary 15, 2021 Seelos Therapeutics Announces Dosing of the First Patients in a Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder
PressJanuary 14, 2021 MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience
PressJanuary 12, 2021 MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers
PressJanuary 11, 2021 Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics
InterviewsJanuary 8, 2021 Fluence: Training the Next Generation of Psychedelic Treatment Professionals
PressJanuary 8, 2021 COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
PressJanuary 7, 2021 MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand
PressJanuary 6, 2021 Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research
Market ResearchJanuary 5, 2021 Novamind Goes Public and Carves Foothold In the Psychedelic Industry With a Unique Strategy in Mind
Market ResearchJanuary 4, 2021 Psychedelic Invest Index Gains 2.23% In December as Daily Volumes Surge
PressJanuary 4, 2021 Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange
PressDecember 29, 2020 Better Plant’s Subsidiary NeonMind to Complete Fully Subscribed IPO and Commence Trading on Monday, January 4, 2021 under the symbol NEON
PressDecember 29, 2020 Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized
PressDecember 28, 2020 Red Light Holland Announces Exercise of Warrants for Gross Proceeds of Over $5 Million
InterviewsDecember 23, 2020 CaaMTech: Utilizing the Entourage Effect to Transform Psychedelic Medicine
PressDecember 23, 2020 Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”
PressDecember 22, 2020 MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program
PressDecember 21, 2020 BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC
